StonvexLoading…
StonvexStonvexStonvexCore line items from AGX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $944.61M | $874.18M | $573.33M | $455.04M |
Operating Income | $134.70M | $88.19M | $36.46M | $41.67M |
Net Income | $137.77M | $85.46M | $32.36M | $33.10M |
EPS (Diluted) | $9.74 | $6.15 | $2.39 | $2.33 |
Total Assets | $1.19B | $836.23M | $598.23M | $489.49M |
Total Liabilities | $724.09M | $484.37M | $307.29M | $208.59M |
Cash & Equivalents | $339.48M | $145.26M | $197.03M | $173.95M |
Free Cash Flow OCF − CapEx | $410.84M | $161.00M | $114.10M | $-33.43M |
Shares Outstanding | 13.95M | 13.63M | 13.24M | 13.44M |